Recommended Treatment for Coronary Calcium Score of 335
With a calcium score of 335, you should initiate high-intensity statin therapy immediately, along with aspirin 81 mg daily, and aggressively address all modifiable cardiovascular risk factors. 1
Risk Stratification
A CAC score of 335 places you firmly in the high-risk category (>100 and approaching the very high-risk threshold of ≥400). This score indicates:
- Established coronary atherosclerosis with significant plaque burden
20% 10-year risk of major adverse cardiovascular events 2
- Number needed to treat (NNT) of approximately 12-30 patients over 5-10 years to prevent one cardiovascular event—among the most favorable treatment ratios in preventive cardiology 3, 4
Core Pharmacotherapy
Statin Therapy (Primary Intervention)
High-intensity statin therapy is mandatory at this calcium score level 1, 5. The evidence shows:
- Statin benefit is directly proportional to CAC severity, with the greatest absolute risk reduction in scores >100 4
- Consider rosuvastatin 20-40 mg or atorvastatin 40-80 mg daily
- Target LDL-C reduction of ≥50% from baseline, ideally to <70 mg/dL (or even <55 mg/dL given high risk)
Add ezetimibe 10 mg daily if LDL-C targets are not achieved with statin monotherapy 6. The combination of rosuvastatin plus ezetimibe has demonstrated effectiveness in reducing cardiovascular events with minimal adverse effects.
Aspirin Therapy
Aspirin 81 mg daily is recommended for CAC scores >100 1, 2. While the evidence is more robust for statins, aspirin provides additional antiplatelet protection in established atherosclerosis, and your score of 335 clearly demonstrates coronary disease presence.
Aggressive Risk Factor Management
Beyond pharmacotherapy, address these modifiable factors systematically:
Blood Pressure Control
- Target <130/80 mmHg (or <120/80 if tolerated without adverse effects)
- Initiate or intensify antihypertensive therapy as needed
Lipid Management Beyond Statins
- Monitor and treat elevated triglycerides (target <150 mg/dL)
- Address low HDL-C if present
- Consider checking lipoprotein(a) and apolipoprotein B levels—if elevated, these justify even more aggressive LDL-C lowering
Metabolic Optimization
- Screen for and aggressively manage diabetes (HbA1c <7%)
- Address metabolic syndrome components
- Evaluate for chronic kidney disease
Lifestyle Modifications (Non-Negotiable)
- Diet: Mediterranean or DASH diet pattern
- Exercise: Minimum 150 minutes moderate-intensity aerobic activity weekly
- Smoking: Absolute cessation if applicable—this is critical
- Weight: Achieve and maintain healthy BMI
Important Clinical Caveats
What NOT to Do
Do not pursue coronary angiography or stress testing unless you develop symptoms 5. Your score indicates atherosclerosis presence, but revascularization does not improve outcomes in asymptomatic individuals with preserved left ventricular function. Treatment is medical, not interventional.
Monitoring Strategy
- Lipid panel: Recheck 4-6 weeks after statin initiation, then every 3-6 months until at goal
- Liver enzymes and CK: Baseline and as clinically indicated (routine monitoring not required unless symptomatic)
- Repeat CAC scanning: Generally not recommended routinely 2, though some advocate rescanning in 3-5 years if initial management adherence is poor or to motivate continued therapy
Patient Motivation
The presence of measurable coronary calcium often significantly improves medication adherence and lifestyle modification 3. Your score of 335 represents years of plaque accumulation—but the good news is that aggressive treatment at this stage can substantially reduce your risk of heart attack and cardiovascular death.
Treatment Intensity Justification
The evidence strongly supports aggressive intervention at your calcium score level. Studies demonstrate that patients with CAC >100 have an NNT of 28-30 to prevent one ASCVD event over 10 years with statin therapy 3—this is among the most cost-effective interventions in all of medicine. The higher your score, the greater the absolute benefit from treatment 4.
The time to act is now. Delaying treatment allows continued plaque progression and increased cardiovascular risk. Every myocardial infarction is preventable with appropriate early intervention 6.